Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma 217Precursor Cell Lymphoblastic Leukemia-Lymphoma 192Lymphoma, Large B-Cell, Diffuse 173Burkitt Lymphoma 91Lymphoma, Non-Hodgkin 90Leukemia 80Lymphoma, Follicular 79Lymphoma, Mantle-Cell 53Hodgkin Disease 46Lymphoma, B-Cell 31Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30Lymphoma, Large-Cell, Anaplastic 29Lymphoma, T-Cell, Peripheral 28Lymphoma, Large-Cell, Immunoblastic 27Recurrence 24Lymphoma, B-Cell, Marginal Zone 22Leukemia, Lymphocytic, Chronic, B-Cell 21Lymphoma, T-Cell 17Leukemia, Biphenotypic, Acute 17Dendritic Cell Sarcoma, Interdigitating 17Immunoblastic Lymphadenopathy 16Neoplasms 14Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 11HIV Infections 10Waldenstrom Macroglobulinemia 7Enteropathy-Associated T-Cell Lymphoma 7Blast Crisis 7Multiple Myeloma 6Lymphoma, T-Cell, Cutaneous 6Lymphoma, AIDS-Related 6

Interventions

Zidovudine 2Vincristine 2Valganciclovir 2Rituximab 2Prednisone 2Etoposide 2Doxorubicin 2Cyclophosphamide 2tocilizumab 1tanespimycin 1liposomal doxorubicin 1ibrutinib 1deltacortene 1Sirolimus 1Polymerase Chain Reaction 1Methotrexate 1Interferon-alpha 1Hyaluronoglucosaminidase 1Histological Techniques 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1CT-P10 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Multi-centric Castleman's Disease × Vincristine × Lymphoid × Clear all
NCT00092222 2026-06-01

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

NCT03864419 2024-01-03

Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda

Fred Hutchinson Cancer Center

Phase 1 Terminated
18 enrolled
Lymphoid

Multi-centric Castleman's Disease, Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡